Become a Member

Search Results for: Antabuse 500mg ohne rezept kaufen.šŸ½šŸ¦¼ www.MayoClinic.store šŸ¦¼šŸ½ Provigil 200mg kaufen ohne rezept billiger. Billig allopurinol tabletten kaufen ohne rezept online kaufen.

This article was originally published on January 11, but the Casey folks are promoting these same five stocks quite similarly with the bait of their “Become a Marijuana Millionaire in 2018” report, focusing on the impending Canadian legalization this summer, so we’re re-posting our January article here to answer some reader questions. The five stocks […]

I’ve gotten quite a few questions about the latest pitch from Ian Wyatt for his $100K Portfolio newsletter — this is his letter that tracks the trades of a $100,000 real money portfolio of his own money, started up a couple years ago when every newsletter publisher was trying out a “real money” letter. I […]

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for ourĀ Irregulars. He chooses his own topics, and his words and opinions are his own. He has agreed to our trading restrictions. Visit his Stock Gumshoe page for more.] Bacteria are prokaryotes. Animal cells, fungi and plants are eukaryotes. Prokaryotes tend to be acellular and […]

[ed. note: Michael Jorrin, who I like to call Doc Gumshoe, is a longtime medical writer (not a doctor) who writes about non-financial health and medical issues for us a couple times a month. Like all of our authors, he chooses his own topics and his words and opinions are his alone. Enjoy!] While working […]

Mark Boyar is a well-respected longtime value investor, he publishes a research-intensive newsletter and has an excellent record over many decades. He first mentioned the stocks that he talked about last time he presented, at the Las Vegas iteration of this Congress back in May (we covered that here) — he did well with Dole […]

I’ve gotten quite a few questions about the latest pitch from Ian Wyatt for his $100K Portfolio newsletter — this is his letter that tracks the trades of a $100,000 real money portfolio of his own money, started up a couple years ago when every newsletter publisher was trying out a “real money” letter. I […]

Here’s the first part of an email inviting to join a free online event. What are your thoughts. ———————— On January 1, 2014, dozens of new tax laws – many of them a result of Obamacare – will blindside millions of American taxpayers. They include hikes in capital gains and dividend taxes… an increase in […]

Mark Boyar is a well-respected longtime value investor, he publishes a research-intensive newsletter and has an excellent record over many decades. He first mentioned the stocks that he talked about last time he presented, at the Las Vegas iteration of this Congress back in May (we covered that here) — he did well with Dole […]

Guy Gottfried has a nice, albeit short, record of choosing excellent little Canadian value stocks that have risen in value pretty substantially over the year or so following his presentation. Of course, that doesn’t mean his pick this year will jump right up — but he’s presenting before the market opens, and the 500 or […]

Any idea what company Frank Curzio (Editor, Small Stock Specialist) * A Real, ”Cash-In-Your-Hand” 30% Dividend Why isn’t anyone talking about the biggest, most outrageous dividends in the public markets? I’m talking about a real, ”cash-in-your-hand” dividend so large it could change your life. What’s more, these are actually some of the safest ā€“ if […]

“This is the only company in the online higher education industry thatā€™s creating a win-win for everyone. Which means itā€™s the only one with long-term staying power. The sad truth is, most online colleges exist for one simple purpose. To suck away federal loan dollars from Uncle Sam. These ā€œdiploma millsā€ donā€™t even care whether […]

1 14 15 16 17 18 24

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

More Info